Correction to “Structure–Activity Relationships of the Fentanyl Scaffold: Identification of Antagonists as Potential Opioid Overdose Reversal Agents”

IF 4.1 3区医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY

ACS Chemical Neuroscience Pub Date : 2024-09-18 DOI:10.1021/acschemneuro.4c00579

Jessica P. Anand, Sierra C. Moore, Emma E. Dixon, Carmelita M. Perrien Naccarato, Joshua L. West, Lennon J. Delong, Emily Burgess, Jack J. Twarozynski, John R. Traynor

引用次数: 0

Abstract

The incorrect Table 1 was uploaded during galley proofs. The correct table is below. This article has not yet been cited by other publications.

查看原文本刊更多论文

对 "芬太尼支架的结构-活性关系：确定作为潜在阿片类药物过量逆转剂的拮抗剂 "的更正

校样时上传了错误的表 1。正确的表格如下。本文尚未被其他出版物引用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

ACS Chemical Neuroscience BIOCHEMISTRY & MOLECULAR BIOLOGY-CHEMISTRY, MEDICINAL

CiteScore

9.20

自引率

4.00%

发文量

323

审稿时长

1 months

期刊介绍： ACS Chemical Neuroscience publishes high-quality research articles and reviews that showcase chemical, quantitative biological, biophysical and bioengineering approaches to the understanding of the nervous system and to the development of new treatments for neurological disorders. Research in the journal focuses on aspects of chemical neurobiology and bio-neurochemistry such as the following: Neurotransmitters and receptors Neuropharmaceuticals and therapeutics Neural development—Plasticity, and degeneration Chemical, physical, and computational methods in neuroscience Neuronal diseases—basis, detection, and treatment Mechanism of aging, learning, memory and behavior Pain and sensory processing Neurotoxins Neuroscience-inspired bioengineering Development of methods in chemical neurobiology Neuroimaging agents and technologies Animal models for central nervous system diseases Behavioral research